Ann: Appendix 4E - Preliminary final report-unaudited, page-23

First 23 Last

Share
Profile

Follow
bioqld

522 Posts.

165

25/11/21

12:41

Post #: 57847937
Share
Originally posted by bioqld: ↑

Hi All, been a while..

Curious, dare I say encouraging LinkedIn post below..

"Regeneus is well on track to fulfil its obligations under our licence and collaboration agreement withKYOCERA Globalfor osteoarthritis in Japan and earn future milestone payments and royalties.
Hear more from Regeneus CEOKarolis Rosickason the Company's strategy for its lead stem cell technology platform Progenza™ in Japan.#regenmed #regenerativemedicine #CEOtalks"
Reviewing the Kyocera deal - there may be up to $AUD11m remaining in upfront payment to be received. Whether its all in one hit, perhaps unlikely. If the full amount were to be received, that would represent 50% of current MC (AUD$22m). Also unlikely would be the full reflection of MC change in SP change - no particular reason other than history and some expectation already factored in (though hard to sell that case given the current SP)

Not including any future milestones or royalties. Certainly the most optimistic I have been for SOME TIME - that being said, I'm still out when money back or close (SP @ $0.125)
Upfront payments, milestone payments and royalties
Regeneus will receive US$19 million (A$27m) in upfront and milestone payments from Kyocera consisting of:
US$9 million (A$13m) upfront payment, of which A$2m was received as part of the MOU
US$10 million (A$14m) in regulatory and development milestone payments
Additionally, Regeneus will receive single to high double-digit royalties on all future Progenza OA product sales in Japan based on future reimbursement prices
Upfront payments expected to provide sufficient cash runway for Regeneus until the commercial launch of Progenza OA in Japan

Fingers Crossed.
Merry Xmas.

Expand

Unless I have missed some or all of that additional AUD$11m come in.. quite possible
RGS Price at posting: 7.3¢ Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

GDC

Global Data Centres not clear on future operations after AirTrunk sale payout

CNB

Carnaby Resources hits copper at Mohawk, QLD

RMX

Red Mountain Mining: record gold prices, two projects, two greenstone belts

YAL

Yancoal makes it into the ASX200 in latest S&P rebalance

CBL

Control Bionics expands into UK and Irish markets with NeuroNode device

There are more pages in this discussion • 2 more messages in this thread...

First 23 Last

Add CMB (ASX) to my watchlist

(20min delay)
Last 30.0¢		Change -0.005(1.64%)		Mkt cap ! $3.579M

Open	High	Low	Value	Volume
30.0¢	30.0¢	30.0¢	$5	16

Buyers (Bids)

No.	Vol.	Price($)
1	500	33.0¢

Sellers (Offers)

Price($)	Vol.	No.
39.5¢	13403	1

View Market Depth

No.	Vol.	Price($)
2	17	0.305
1	1482	0.300
1	2000	0.290
1	3000	0.195
0	0	0.000

Price($)	Vol.	No.
0.395	13403	1
0.400	7905	1
0.500	4000	1
0.000	0	0
0.000	0	0

Last trade - 10.02am 09/09/2024 (20 minute delay)

CMB (ASX) Chart

Ann: Appendix 4E - Preliminary final report-unaudited, page-23

Global Data Centres not clear on future operations after AirTrunk sale payout

Carnaby Resources hits copper at Mohawk, QLD

Red Mountain Mining: record gold prices, two projects, two greenstone belts

Yancoal makes it into the ASX200 in latest S&P rebalance

Control Bionics expands into UK and Irish markets with NeuroNode device

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Appendix 4E - Preliminary final report-unaudited, page-23

Top Stories

Global Data Centres not clear on future operations after AirTrunk sale payout

Carnaby Resources hits copper at Mohawk, QLD

Red Mountain Mining: record gold prices, two projects, two greenstone belts

Yancoal makes it into the ASX200 in latest S&P rebalance

Control Bionics expands into UK and Irish markets with NeuroNode device

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News